Stay updated on Remibrutinib for CSU: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Remibrutinib for CSU: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Remibrutinib for CSU: Efficacy & Safety Clinical Trial page

  1. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T19:20:48.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    23 days ago
    Change Detected
    Summary
    The webpage has undergone significant content removal regarding a clinical study on remibrutinib for chronic spontaneous urticaria, including details about the study's purpose, design, and inclusion/exclusion criteria. Additionally, the revision number has been updated to v2.15.0.
    Difference
    17%
    Check dated 2025-04-16T13:17:47.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The webpage has been updated with new dates and a revision number, indicating a recent update to the content. Additionally, a new resource link from Novartis Pharmaceuticals has been added.
    Difference
    1%
    Check dated 2025-04-09T06:48:00.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:45:41.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.8%
    Check dated 2025-02-24T20:38:50.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    0.9%
    Check dated 2025-02-10T09:47:03.000Z thumbnail image

Stay in the know with updates to Remibrutinib for CSU: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Remibrutinib for CSU: Efficacy & Safety Clinical Trial page.